Thu, Oct 12, 2023
Glenmark Pharma news: With the execution of this agreement, Ichnos has successfully licensed its two assets for inflammatory and immunological diseases, a key milestone in the company's prioritisation of its pipeline of oncology drug candidates, Ichnos Sciences said in a statement filed on BSE by Glenmark.
More >
Tue, Oct 10, 2023
Glenmark Life's board on Monday declared an interim dividend for the financial year 2023-24 of Rs. 22.50/- per equity of the share face value of Rs. 2 each.
Mon, Oct 09, 2023
Glenmark Life Sciences in its board meeting today (October 9) announced an interim dividend of Rs 22.5 per share.
Fri, Sep 29, 2023
Positive S&P on Glenmark Pharma. S&P changed the company's outlook from stable to positive. Outlook improved due to sale of 75% stake in Glenmark Life
Last seen, shares of Glenmark Pharma traded 5.17 per cent higher at Rs 818.20 apiece. The market capitalisation of the company stood at around Rs 23,127 crore. The stock continued its rally for the third consecutive session.
Fri, Sep 22, 2023
Glenmark Pharma Nirma news: Glenmark Pharmaceuticals announced the divestment of a 75 per cent stake in its subsidiary, 'Glenmark Life Sciences'. An agreement has been signed with Nirma Limited for a share sale. The company will sell 91.89 crore shares at the price of Rs 615 per share.
Thu, Sep 21, 2023
Glenmark Pharma's big deal, GlenmarkPharma has sold 75% stake in its subsidiary GLS.
Mon, Jun 12, 2023
Glenmark Life Sciences share price: The scrip zoomed after reports said that Mumbai-based pharmaceutical company Sekhmet Pharmaventures and Ahmedabad-based Nirma Group are in race to acquire Glenmark Life Sciences.
Thu, May 18, 2023
Glenmark Pharma results will come tomorrow. How will be the income, profit, margin in Q4? How will be US sales in Q4? Know full details from Nupur.
Mon, Apr 03, 2023
Stocks to buy this week: In conversation with Zee Business, market experts Himanshu Gupta, Vishvesh Chauhan, Sumeet Bagadia and Sandeep Jain share their top recommendations for the holiday-truncated week between April 3-7, 2023.
Mon, Mar 13, 2023
Stocks to buy this week: Market experts have lined up their stock recommendations for the March 13-17 trading week. On their 'buy' list stocks such as Maruti Suzuki, Glenmark, ONGC, and Shree Cement.
Wed, Dec 21, 2022
To review the Covid preparedness, Union Health Minister Mansukh Mandaviya chaired a meeting with top officials as fresh spurt in cases in countries like Japan, South Korea, Brazil, China, and the US.
Mon, Dec 19, 2022
For the 12-month period ended October 2022, the Cardene capsules 20 mg and 30 mg achieved annual sales of approximately USD 10.9 million, the company said citing IQVIATM sales data.
Sat, May 28, 2022
Consolidated revenues of the drug firm, however, rose to Rs 3,019 crore in the quarter under review as compared to Rs 2,860 crore in the year-ago period.
Fri, May 20, 2022
Glenmark Pharmaceuticals Ltd on Friday said that its US arm has received final approval from the US health regulator for its generic version of Abiraterone Acetate tablets used for the treatment of prostate cancer
Tue, Sep 21, 2021
Glenmark Pharmaceuticals on Tuesday said it has received approval from the US health regulator to market Clindamycin Phosphate Foam, an antibiotic used for treating bacterial infections, in the American market.
Mon, Jul 05, 2021
In a pick of the week segment, the stock market analysts in a conversation with Zee Business Managing Editor Anil Singhvi picked their favourites from beverages to paint sector for bumper returns.
Sun, Jul 04, 2021
Top Stocks to Buy – Nilkamal Limited – Another stock picked by him was Nilkamal Limited and it was from the cash market. The stock ended at Rs 2272 on the NSE on Friday. He puts the target price at Rs 2370 and next target price at Rs 2410. He puts the stop loss at Rs 2230.
Wed, Jun 09, 2021
Zee Business Senior Research Analysts Varun Dubey and Kushal Gupta recommends a list of mid cap and small-cap shares from different sectors for bumper returns. Know which stocks were picked by them and what levels will give high returns.
Tue, Jun 01, 2021
Days after its fourth-quarter results, the brokerages post a mixed sentiment for Glenmark Pharma, which reported a growth in profit by six per cent to Rs 234 crores year-on-year (YoY) basis.
Mon, Apr 19, 2021
Glenmark Life Sciences Ltd, a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd, has filed a draft red herring prospectus with the Securities and Exchange Board of India (SEBI) for an Initial Public Offer (IPO) to raise Rs 1,160 crore.
Vishal Wagh, Research Head at Bonanza Portfolio says that Nifty pharma has shown consistent outperformance to the major indices and the current pandemic environment is creating a large demand for the sector. He said that as per ranking based on its performance against the NIFTY and Nifty Pharma, Cadila, Glenmark, Cipla, Sun pharma, Divislab, Auropharma, Lupin and Dr Reddy will outperform in the sector whereas, Biocon, Alkem, APL and Granules may underperform
Sat, Apr 17, 2021
Glenmark Pharma share price: Glenmark Life Sciences Limited, a wholly owned subsidiary of Glenmark Pharmaceuticals filed a draft red herring prospectus with the Securities and Exchange Board of India (SEBI) for an initial public offer
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
